InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by BOLGER JOHN C, Director. Director active across 1 companies, notably Fulgent Genetics, Inc.. Cumulatively, 11 filings have been published. Total volume traded: €15k. The latest transaction was filed on 31 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
€1,145313 shares@ €3.65660.0003% mcap5.0% of flow
Common Stock
SEC:0001209191-22-033477:0·
02,000 shares0
Common Stock
SEC:0001209191-22-030954:0·
€2,187625 shares@ €3.49950.0005% mcap9.6% of flow
Common Stock
SEC:0001209191-22-015590:0·
€1,038312 shares@ €3.32710.0002% mcap10.7% of flow
Common Stock
SEC:0001209191-21-054292·
€1,038312 shares@ €3.32710.0002% mcap4.6% of flow
Common Stock
SEC:0001209191-21-054292:0·
€7,641125 shares@ €61.13080.0017% mcap78.9% of flow
Common Stock
SEC:0001209191-21-038717·
€7,641125 shares@ €61.13080.0017% mcap33.7% of flow
Common Stock
SEC:0001209191-21-038717:0·
€1,007313 shares@ €3.21660.0002% mcap10.4% of flow
Common Stock
SEC:0001209191-21-037821·
€1,007313 shares@ €3.21660.0002% mcap4.4% of flow
Common Stock
SEC:0001209191-21-037821:0·
02,000 shares0
Common Stock
SEC:0001209191-21-035449·
02,000 shares0
Common Stock
SEC:0001209191-21-035449:0·
11 of 11 declarations
About BOLGER JOHN C
John C. Bolger is a Board Member at Fulgent Genetics, Inc. He plays a key role in the governance of the company, bringing his expertise in biotechnology and management. His involvement is essential in guiding strategic decisions.
